Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda.
Spacek LA, Shihab HM, Lutwama F, Summerton J, Mayanja H, Kamya M, Ronald A, Margolick JB, Nilles TL, Quinn TC. Spacek LA, et al. Among authors: mayanja h. J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):607-10. doi: 10.1097/01.qai.0000214807.98465.a2. J Acquir Immune Defic Syndr. 2006. PMID: 16652034
Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count.
Chamie G, Charlebois ED, Srikantiah P, Walusimbi-Nanteza M, Mugerwa RD, Mayanja H, Okwera A, Whalen CC, Havlir DV. Chamie G, et al. Among authors: mayanja h. Clin Infect Dis. 2010 Aug 1;51(3):359-62. doi: 10.1086/654799. Clin Infect Dis. 2010. PMID: 20569064 Free PMC article. Clinical Trial.
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Podany AT, Pham M, Sizemore E, Martinson N, Samaneka W, Mohapi L, Badal-Faesen S, Dawson R, Johnson JL, Mayanja H, Lalloo U, Whitworth WC, Pettit A, Campbell K, Phillips PPJ, Bryant K, Scott N, Vernon A, Kurbatova EV, Chaisson RE, Dorman SE, Nahid P, Swindells S, Dooley KE, Fletcher CV. Podany AT, et al. Among authors: mayanja h. Clin Infect Dis. 2022 Sep 10;75(4):560-566. doi: 10.1093/cid/ciab1037. Clin Infect Dis. 2022. PMID: 34918028 Free PMC article. Clinical Trial.
Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. Uganda-Case Western Reserve University Research Collaboration.
Pekovic V, Mayanja H, Vjecha M, Johnson J, Okwera A, Nsubuga P, Mugerwa R, Ellner J, Whalen C. Pekovic V, et al. Among authors: mayanja h. J Clin Epidemiol. 1998 Jul;51(7):597-607. doi: 10.1016/s0895-4356(98)00033-x. J Clin Epidemiol. 1998. PMID: 9674667 Clinical Trial.
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
Johnson JL, Okwera A, Hom DL, Mayanja H, Mutuluuza Kityo C, Nsubuga P, Nakibali JG, Loughlin AM, Yun H, Mugyenyi PN, Vernon A, Mugerwa RD, Ellner JJ, Whalen CC; Uganda-Case Western Reserve University Research Collaboration. Johnson JL, et al. Among authors: mayanja h. AIDS. 2001 Nov 9;15(16):2137-47. doi: 10.1097/00002030-200111090-00009. AIDS. 2001. PMID: 11684933 Clinical Trial.
Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.
Johnson JL, Ssekasanvu E, Okwera A, Mayanja H, Hirsch CS, Nakibali JG, Jankus DD, Eisenach KD, Boom WH, Ellner JJ, Mugerwa RD; Uganda-Case Western Reserve University Research Collaboration. Johnson JL, et al. Among authors: mayanja h. Am J Respir Crit Care Med. 2003 Jul 15;168(2):185-91. doi: 10.1164/rccm.200211-1359OC. Epub 2003 Apr 17. Am J Respir Crit Care Med. 2003. PMID: 12702550 Clinical Trial.
35 results